Afsaneh Mojtabanezhad Shariatpanahi awarded four-year doctoral fellowship (4YF)
Congratulations to Afsaneh who has been awarded a 4YF from the IOP program for her project entitled “Elucidating the molecular mechanism of high-risk multiple myeloma”.
News
Liam MacPhee (Kuchenbauer Lab) awarded BC Graduate Scholarship
Congratulations to Liam who has been awarded a B.C. Graduate Scholarship for his project entitled “Investigating the anti-leukemic effects of tumor-suppressor microRNAs in acute myeloid leukemia”.
Sibyl Drissler (Hoodless Lab) awarded CIHR Canada Graduate Scholarship Master's (CGSM) Award
Congratulations to Sibyl Drissler (Hoodless Lab) who has been awarded a CIHR Canada Graduate Scholarship Master's (CGSM) Award.
Louis-Alexandre Fournier (Stirling Lab) awarded CIHR Doctoral Award (Frederick Banting and Charles Best Canada Graduate Scholarship)
Congratulations to Louis-Alexandre Fournier (Stirling Lab) who has been awarded a CIHR Doctoral Award (Frederick Banting and Charles Best Canada Graduate Scholarship) for his project entitled “Investigating the role of ARID1A loss in cancer and its effects on R-loop accumulation and genome instability”.
Sherrie X Wang (Brinkman Lab) defends her MSc thesis entitled “Flow cytometry data analysis pipeline – data quality control tool development and biomarker discovery”
Congratulations to Sherrie X Wang from the Brinkman Lab, who successfully defended her MSc thesis entitled “Flow cytometry data analysis pipeline – data quality control tool development and biomarker discovery” on April 8, 2020.
Carl-Adam Mattsson (Lansdorp Lab) defends his MSc thesis entitled “A bioinformatic workflow to analyze single cell template strand sequencing data"
Congratulations to Carl-Adam Mattsson from the Lansdorp Lab, who successfully defended his MSc thesis entitled “A bioinformatic workflow to analyze single cell template strand sequencing data" on April 6, 2020.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.